Evidence map›Paper›PMID 41044342›Full record

ArticleNature neuroscience2025

Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models.

Ariel Ionescu, Lior Ankol, Anand Ganapathy Subramaniam, Topaz Altman, Iddo Magen, Yahel Cohen, Yehuda Danino, Tal Gradus-Pery, Yoav Niv, Ori Bar Avi and 17 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Ariel Ionescu *Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.ORCID http://orcid.org/0000-0002-9889-5628
Lior Ankol *Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Anand Ganapathy SubramaniamFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Topaz AltmanFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Iddo MagenDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Yahel CohenDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Yehuda DaninoDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Tal Gradus-PeryFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Yoav NivFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Ori Bar AviFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Danielle GellerFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Amjd IbraheemFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Ruilei ChengFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Noam SteinbergFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Leenor AlfahelDepartment of Physiology and Cell Biology, Ben-Gurion University of the Negev, Beersheba, Israel.
Pauline DucInstitut de Génétique Moléculaire de Montpellier, IGMM UMR535, Montpellier, France.
Zeynep Ergul-UlgerDepartment of Neurology, Neuromuscular Diseases Research Laboratory, Hacettepe University, Altındağ, Turkey.
Doruk ArslanDepartment of Neurology, Neuromuscular Diseases Research Laboratory, Hacettepe University, Altındağ, Turkey.ORCID http://orcid.org/0000-0003-4270-3217
Ersin TanDepartment of Neurology, Neuromuscular Diseases Research Laboratory, Hacettepe University, Altındağ, Turkey.
Florence RageInstitut de Génétique Moléculaire de Montpellier, IGMM UMR535, Montpellier, France.
Nilo Riva3rd Neurology Unit and Motor Neuron Disease Centre, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Angello QuattriniInstitute of Experimental Neurology (INSPE), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Can Ebru Bekircan-KurtDepartment of Neurology, Neuromuscular Diseases Research Laboratory, Hacettepe University, Altındağ, Turkey.
Adrian IsraelsonDepartment of Physiology and Cell Biology, Ben-Gurion University of the Negev, Beersheba, Israel.
Amir DoriFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.ORCID http://orcid.org/0000-0003-4633-1481
Eran HornsteinDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-5534-1924
Eran PerlsonFaculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel. eranpe@tauex.tau.ac.il.ORCID http://orcid.org/0000-0001-6047-9613

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by neuromuscular junction (NMJ) disruption and neurodegeneration. Recent findings highlight a pivotal role for TAR DNA-binding protein 43 (TDP-43) in forming axonal pathological condensates and facilitating NMJ disruption through inhibition of local protein synthesis. However, the mechanisms that drive local TDP-43 accumulation remain unknown. Here we identify that the TDP-43 axonal accumulation in peripheral nerves of SOD1 patients and mice stems from its aberrant local synthesis. This is a non-cell-autonomous process driven by muscle-derived miR-126a-5p extracellular vesicles (EVs). Inhibiting muscle secretion of miR-126a-5p prompts presynaptic TDP-43 synthesis and accumulation, which disrupts axonal translation and causes NMJ degeneration. Introducing miR-126 to SOD1

Indexed as

Amyotrophic Lateral SclerosisAxonsDNA-Binding ProteinsMicroRNAsMuscle, SkeletalNeuromuscular JunctionAnimalsDisease Models, AnimalExtracellular VesiclesHumansInduced Pluripotent Stem CellsMaleMiceMice, TransgenicMotor NeuronsSuperoxide Dismutase-1DNA-Binding ProteinsMicroRNAsMIRN126 microRNA, mouseSuperoxide Dismutase-1TARDBP protein, humanTardbp protein, mouse

Identifiers

PMID41044342
PMCPMC12586178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.